Standard Biotools (LAB) Cash from Operations Growth (5y) (2015 - 2026)
Standard Biotools (LAB) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.85% |
| Mar 31, 2026 | -29.28% |
| Dec 31, 2025 | 20.44% |
| Sep 30, 2025 | -37.01% |
| Jun 30, 2025 | -49.26% |
| Mar 31, 2025 | -47.79% |
| Dec 31, 2024 | -20.56% |
| Sep 30, 2024 | -43.70% |
| Jun 30, 2024 | -50.77% |
| Mar 31, 2024 | -25.42% |
| Dec 31, 2023 | -85.63% |
| Sep 30, 2023 | -22.94% |
| Jun 30, 2023 | -16.63% |
| Mar 31, 2023 | 12.11% |
| Dec 31, 2022 | -98.76% |
| Sep 30, 2022 | -25.26% |
| Jun 30, 2022 | -29.32% |
| Mar 31, 2022 | -12.93% |
| Sep 30, 2021 | -22.82% |
| Jun 30, 2021 | -30.25% |